These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 2942342

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE, Thompson B.
    Am J Med; 1986 May 30; 80(5C):53-8. PubMed ID: 3636060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillin.
    Choi C, Bayer AS, Fujita NK, Lam K, Guze LB, Yoshikawa TT.
    Chemotherapy; 1983 May 30; 29(4):303-12. PubMed ID: 6872621
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS, Norman D, Kim KS.
    Antimicrob Agents Chemother; 1985 Dec 30; 28(6):781-5. PubMed ID: 3909954
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ciprofloxacin, azlocillin, ceftizoxime and amikacin alone and in combination against gram-negative bacilli in an infected chamber model.
    Bamberger DM, Peterson LR, Gerding DN, Moody JA, Fasching CE.
    J Antimicrob Chemother; 1986 Jul 30; 18(1):51-63. PubMed ID: 3093445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model.
    Xiong YQ, Caillon J, Kergueris MF, Drugeon H, Baron D, Potel G, Bayer AS.
    Antimicrob Agents Chemother; 1997 Apr 30; 41(4):823-6. PubMed ID: 9087497
    [Abstract] [Full Text] [Related]

  • 18. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX, Jules K, Neu HC.
    Eur J Clin Microbiol; 1986 Feb 30; 5(1):23-8. PubMed ID: 2938945
    [Abstract] [Full Text] [Related]

  • 19. [Bacteriostatic activity of azlocillin, gentamycin, amikacin singly or in combination on 200 strains of Pseudomonas aeruginosa].
    Texier-Maugein J, Fourche J, Mormede M, Mazaud C, Bébéar C.
    Pathol Biol (Paris); 1986 May 30; 34(5):415-8. PubMed ID: 3095774
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.